Research Brief · November 8, 2023

Andrographis for Colds: What the Research Actually Shows

The bitterest herb in the cold aisle has better trials than you'd guess — and worse ones than you'd hope.

Cold season is here, and the supplement aisle’s usual suspects — vitamin C, zinc, echinacea, elderberry — are back on endcaps. But there’s a lesser-known herb with a more interesting research file than most of them: Andrographis paniculata, sometimes called “Indian echinacea” or by its evocative traditional name, “king of bitters.”

Andrographis has been used in Ayurvedic and traditional Chinese medicine for centuries, primarily for fevers and respiratory complaints. What sets it apart from most traditional herbs is that it has actually been put through a decent number of randomized controlled trials for upper respiratory symptoms. The results are genuinely intriguing — and genuinely flawed. Both halves of that sentence matter, so let’s take them in turn.

What the Trials Suggest

The core research question has been simple: if you take andrographis extract when a cold starts, do your symptoms get better faster or feel less severe than with placebo?

Across a series of controlled trials — many using a proprietary combination of andrographis and eleuthero (Siberian ginseng) — the answer has leaned yes. Pooled analyses of these trials have reported meaningful reductions in overall symptom severity compared to placebo, with sore throat, cough, and nasal symptoms showing the clearest improvements. Some trials reported benefits appearing within two to four days of starting treatment. A few studies have also explored whether regular use during cold season reduces how often people catch colds at all, with preliminary signals in that direction — though this prevention question has far less data behind it than the symptom-relief question, and we’d treat it as unproven.

The proposed mechanisms center on andrographolide, the plant’s signature bitter compound, which laboratory research suggests has immune-modulating and inflammation-signaling effects. As always, mechanism research tells you a story is plausible, not that it’s true — the trials are the evidence that counts.

Now the Caveats — and They’re Substantial

If the paragraph above sounds better than what we wrote about echinacea’s cold research, it is — but the confidence deserves a haircut for several reasons:

  • One product dominates the literature. A large share of the positive trials studied a single proprietary andrographis-eleuthero formulation, often with manufacturer involvement. Independent replication across different products and research groups is the thing that turns “promising” into “established,” and andrographis doesn’t have enough of it.
  • Study quality is uneven. Reviewers examining this literature have consistently flagged methodological weaknesses — small samples, unclear blinding procedures, and inconsistent outcome measures. The pooled effect could shrink considerably with better trials.
  • Symptom scores are squishy. Cold trials rely on self-rated symptoms, which are exactly the kind of outcome placebo effects and expectation can nudge. Good blinding helps, but a famously bitter herb makes perfect blinding harder than you’d think.

So the fair summary: the evidence is suggestive and better than average for an herb, but not solid enough to call andrographis a proven cold remedy. And to be clear about what the research does and doesn’t address — this is about easing the misery of ordinary cold symptoms, not preventing or treating any disease. Nothing here should delay real medical care for a bad or persistent illness.

Doses and Timing From the Studies

If you want to try andrographis the way the trials used it:

  • Dose: Most positive trials used 340–1,200 mg/day of standardized extract, formulated to deliver roughly 60–100 mg of total andrographolides per day. Standardization matters — look for a label stating andrographolide content (commonly 4–10%), a topic our guide to standardized extracts covers in depth.
  • Timing: Start early — trials began dosing within the first day or two of symptoms — and split the daily amount into two or three doses, taken with food to soften stomach upset.
  • Duration: Short. Symptom trials ran about 3–10 days; even the prevention-style studies rarely exceeded two to three months. There is no long-term daily-use safety file, so this isn’t a year-round herb.
  • Expect bitterness. Capsules solve what teas cannot. “King of bitters” is not a marketing exaggeration.

Safety, Interactions, and Who Should Skip It

Andrographis was generally well tolerated in trials, with side effects mostly limited to mild GI upset, headache, and occasional fatigue. But the cautions are worth taking seriously:

  • Pregnancy and nursing: avoid. Traditional sources and animal research raise concerns about effects on pregnancy, and there’s no human safety data. This one is a firm no rather than a maybe.
  • Autoimmune conditions and immunosuppressants: because andrographis appears to modulate immune activity, it could theoretically work against immunosuppressive therapy. If you take such medications, don’t add this without your prescriber’s sign-off.
  • Blood pressure and blood thinners: limited research suggests possible blood-pressure-lowering and antiplatelet effects. Combined with medication for either, that’s a conversation with your doctor, not a solo experiment.
  • Allergic reactions: rare but reported, as with most botanicals. Stop at any sign of rash or swelling.
  • Fertility note: some animal research has raised questions about effects on male fertility with high doses. Human relevance is unknown, but couples actively trying to conceive may prefer to skip it.

Where It Fits Among Cold-Season Options

Ranked honestly against the alternatives: zinc lozenges started within 24 hours of symptoms probably have the strongest duration-shortening evidence of the lot; elderberry has a small but suggestive file; echinacea’s is large and messy; vitamin C mostly disappoints outside of hard exercisers. Andrographis slots somewhere near the top of the herbal tier for symptom severity — with the asterisk that its evidence base needs independent replication it hasn’t yet received. Our roundup of immune supplements puts the whole field side by side.

The boring fundamentals still dwarf all of it: sleep, hand washing, managing stress, and not running yourself into the ground in November.

Bottom line

Andrographis is one of the more legitimately interesting cold-season herbs: multiple controlled trials suggest standardized extract (60–100 mg andrographolides daily, started early, taken for a few days) can take the edge off cold symptoms. But the evidence leans on one proprietary product and uneven study quality, so hold the enthusiasm to “worth a cautious try,” not “proven.” Skip it entirely if you’re pregnant, nursing, or on immune or blood-pressure medications — and see a doctor for anything worse than a routine cold.

This article is educational and not medical advice. Consult a healthcare provider before starting any supplement — especially if you’re pregnant, nursing, taking medication, or managing a health condition.